Hologic (HOLX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4364401012

(NASDAQ:HOLX Stock) Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Web URL: https://www.hologic.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Hologic (HOLX) - Stock Price & Dividends

HOLX Stock Overview

Market Cap in USD 16,910m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1990-06-21

HOLX Stock Ratings

Fundamental 3.71
Dividend -
Growth 5y 3.53
Rel. Performance vs Sector -2.24
Analysts 3.67
Fair Price Total Ret. 71.28
Fair Price DCF 100.06

HOLX Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

HOLX Growth Ratios

Growth 12m -8.14%
Growth Correlation 12m -52%
Growth Correlation 3m 56%
CAGR 5y 9.68%
CAGR / Mean Drawdown 0.91
Sharpe Ratio 12m -0.71
Alpha vs SP500 12m -31.56
Beta vs SP500 5y weekly 0.86
CAPM 7.61%
Average Daily Range 2m 1.58%
Regime Oscillator 75.32
Volatility GJR Garch 1y 20.58%
Price / SMA 50 2.87%
Price / SMA 200 0.34%
Current Volume 1452.5k
Average Volume 20d 2058.8k
What is the price of HOLX stocks?
As of February 21, 2024, the stock is trading at USD 74.58 with a total of 1,452,544 shares traded.
Over the past week, the price has changed by +1.79%, over one month by +1.44%, over three months by +3.73% and over the past year by -8.14%.
Why is HOLX stock down?
Check with which Index or Commodity HOLX has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return HOLX Return S&P 500
1 Month 1.44% 2.97%
3 Months 3.73% 9.80%
12 Months -8.14% 26.37%
What is the forecast for HOLX stock price target?
According to ValueRays Forecast Model, HOLX Hologic will be worth about 77.1 in February 2025.
Issuer Forecast Upside
Wallstreet Target Price 84.3 13.0%
Analysts Target Price 86.6 16.1%
ValueRay Target Price 77.1 3.3%